Pegfilgrastim Accelerates Neutrophil Engraftment, Reduces the Number of Neutropenic and Hospitalization Days and the Use of Antibiotics After Autologous Peripheral Blood Stem Cell Transplant for Multiple Myeloma and Lymphoma. A Phase II Study and Comparison with a Filgrastim Treated Historical Cohort

---

Autoria(s): Wannesson, L.; Lthi, F.; Zucca, E.; Rosselet, A.; Baglioni, M.; Lerch, E.; Feuerlein, K.; Ghielmini, M.; Ketterer, N.

Data(s)	2009
Identificador	https://serval.unil.ch/notice/serval:BIB_D17529A166D9
Idioma(s)	eng
Fonte	51st Annual Meeting Of The American Society Of Hematology
Tipo	info:eu-repo/semantics/conferenceObject inproceedings